Galapagos

ISIN BE0003818359

WKN A0EAT9

Market cap (in EUR)

1,869 m

Country

Belgium

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Show more Show less

Healthcare Healthcare Services Miscellaneous Healthcare Belgium

Chart

Financials

Key metrics

Market capitalisation, EUR	1,869 m
EPS, EUR	-6.62
P/B ratio	0.8
P/E ratio	19.6
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	276 m
Net income, EUR	-1 m
Profit margin	-0.47%

What ETF is Galapagos in?

There are 3 ETFs which contain Galapagos. All of these ETFs are listed in the table below. The ETF with the largest weighting of Galapagos is the Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist.

ETF	Weight	Investment focus	Fund size (in m EUR)
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing	0.02%	Equity Europe Social/Environmental	33
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	Equity World Social/Environmental	497
Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist	0.04%	Equity Europe Small Cap Climate Change	310

Performance

Returns overview

YTD	+1.11%
1 month	+4.81%
3 months	-3.41%
6 months	+9.25%
1 year	+13.18%
3 years	-33.71%
5 years	-66.43%
Since inception (MAX)	-62.07%
2025	+6.58%
2024	-29.00%
2023	-10.92%
2022	-13.77%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).